by Samsara@8529 | Jan 5, 2022 | Home, News
News Article Samsara Therapeutics Establishes Scientific Advisory Board Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January... by Samsara@8529 | Dec 29, 2021 | Home, News
Insights / News Article More additions to the Samsara Therapeutics team Dec 01, 2021 We’re pleased to report that we’ve further strengthened our team in Oxford. Matthew Williamson is an expert in stem cells and patient-derived assays for Parkinson’s Disease, an... by Samsara@8529 | Jul 2, 2021 | Blog, Home
Insights / Blog Neurodegeneration, lysosomal dysfunction and autophagy By John K. Blackwood and Peter Hamley July 02, 2021 There is a desperate need for novel therapies that can prevent the progressive neurodegeneration in debilitating diseases of ageing, such as... by Samsara@8529 | Jun 7, 2021 | Home, News
Insights / News Article New home and strengthening our scientific team June 02, 2021 June 02, 2021 — It’s a busy time for Samsara Therapeutics as we move into our new purpose-built labs and offices in the Wood Centre for Innovation in Oxford. This is a brand new... by Samsara@8529 | Feb 23, 2021 | Blog, Home
Insights / Blog Autophagy, healthspan and lifespan By Sebastian A. Brunemeier | Feb 23, 2021 Our strategy in Samsara is to treat diseases where there is a high unmet need. But we also want to find out how our molecules work to affect healthspan and longevity.... by Samsara@8529 | Feb 15, 2021 | Blog, Home
Insights / Blog Introducing Samsara By Peter Hamley | Feb 15, 2021 Over the last twenty years or so, the phenomenon of autophagy has become a hot topic in the world of biology. In 2016 Professor Yoshinori Ohsumi was awarded the Nobel Prize for his work on the... 